HealthcarePharmaceuticals & BiotechnologyPharmaceuticals

Medico Remedies Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 34 filings·Updated 29 Sept 2026
Showing 10 of 34 filings.
29 Sept 20266 filings
Company UpdatePrice movement

Significant movement in price has been observed in Medico Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Medico Remedies Limited has submitted their response.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 18:55View Source
Company UpdateGeneral

Medico Remedies clarifies price movement; no pending material disclosures identified

Price movement clarification

  • No pending disclosures; price movement market-driven and information shared with exchanges as required.
Filed 18:39View Source
Company UpdatePrice movement

Significant movement in price has been observed in Medico Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 18:19View Source
Company UpdateClarification

The Exchange has sought clarification from Medico Remedies Ltd on September 29, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 17:45
Insider Trading / SASTClosure of Trading Window

Medico Remedies Limited — Closure of Trading Window from 1st October, 2026 up to the expiry of 48 hours post the date of declaration of the Unaudited Financial Results for the quarter ended 30th September, 2026.

Medico Remedies Limited — Closure of Trading Window from 1st October, 2026 up to the expiry of 48 hours post the date of declaration of the Unaudited Financial Results for the quarter ended 30th September, 2026.

Filed 16:39View Source
Insider Trading / SASTClosure of Trading Window

Medico Remedies Limited — Closure of Trading Window from 1 October 2026 up to the expiry of 48 hours post the date of declaration of the Unaudited Financial Results for the quarter ended 30 September 2026.

Medico Remedies Limited — Closure of Trading Window from 1 October 2026 up to the expiry of 48 hours post the date of declaration of the Unaudited Financial Results for the quarter ended 30 September 2026.

Filed 16:19View Source
23 Sept 20262 filings
AGM/EGMAGM

Medico Remedies 32nd AGM approves all seven resolutions, including MD and director remuneration increases.

AGM Details

  • 32nd AGM held on 22 September 2026 via VC/OAVM.
  • Time 4:00 PM; record date 15 September 2026.
  • Quorum present; total shareholders on record 16,439.

Resolutions and outcomes

  • Resolution 1 (Ord): Adoption of financial statements for year ended 31 March 2026; passed.
  • Resolution 2 (Ord): Re-appointment of Haresh Kapurlal Mehta (retired by rotation); passed.
  • Resolution 3 (Special): Re-appointment of Rishit Mehta as Whole-time Director; passed.
  • Resolution 4 (Special): Re-appointment of Haresh Mehta as Chairman and Whole-time Director; passed.
  • Resolution 5 (Special): Increase in remuneration payable to Harshit Mehta, MD; passed.
  • Resolution 6 (Ord): Increase in professional fees payable to Priyal Rishit Mehta; passed.
  • Resolution 7 (Ord): Increase in remuneration payable to Shweta Harshit Mehta; passed.

Director changes & remuneration approvals

  • Haresh Kapurlal Mehta re-appointed as Whole-time Director.
  • Rishit Mehta re-appointed as Whole-time Director.
  • Haresh Mehta designated as Chairman and WTD.
  • Remuneration for Harshit Mehta (MD) increased.
  • Professional fees for Priyal Rishit Mehta increased.
  • Remuneration for Shweta Harshit Mehta increased.
Filed 16:33View Source
AGM/EGMAGM

Medico Remedies' 32nd AGM approves all seven resolutions including director reappointments and MD remuneration

AGM Details

  • 32nd AGM held on 22 September 2026 at 4:00 PM via VC/OAVM.
  • Record date for voting: 15 September 2026.
  • Quorum met; on-record shareholders 16,439; VC/OAVM attendance: 6 promoters, 28 public.

Resolutions and outcomes

  • Ordinary Resolution 1: Adoption of Financial Statements for year ended 31 March 2026; approved.
  • Special Resolution 2: Re-appointment of Haresh Kapurlal Mehta as Whole-time Director; approved.
  • Special Resolution 3: Re-appointment of Rishit Mehta as Whole-time Director; approved.
  • Special Resolution 4: Re-appointment of Haresh Mehta as Chairman and Whole-Time Director; approved.
  • Special Resolution 5: Increase in remuneration payable to Harshit Mehta, Managing Director; approved.
  • Ordinary Resolution 6: Increase in professional fees payable to Priyal Rishit Mehta; approved.
  • Ordinary Resolution 7: Increase in remuneration payable to Shweta Harshit Mehta; approved.
Filed 16:06View Source
22 Sept 20261 filing
AGM/EGMAGM

Medico Remedies holds 32nd AGM via VC/OAVM with director re-appointments and remuneration increases

AGM Details

  • AGM held on 22 September 2026 at 4:00 PM via VC/OAVM.

Resolutions

  • Adopt audited financial statements for year ended 31 March 2026; outcome not disclosed.
  • Re-appoint Haresh Kapurlal Mehta by rotation.
  • Re-appoint Rishit Mehta as Whole-time Director.
  • Re-appoint Haresh Mehta as Chairman and Whole-Time Director.
  • Increase remuneration for Harshit Mehta, Managing Director.
  • Increase professional fees payable to Priyal Rishit Mehta.
  • Increase remuneration payable to Shweta Harshit Mehta, Regulatory Deputy Manager.
Filed 16:54View Source
29 Aug 20261 filing
Company UpdateGeneral

Medico Remedies announces book closure for 32nd AGM from 16 Sep to 22 Sep 2026

Book Closure for AGM

  • Notice of book closure for 32nd AGM from 16 Sept 2026 to 22 Sept 2026 (inclusive).
  • AGM scheduled on 22 Sept 2026 at 4:00 PM via video conferencing.
  • Register of Members and Share Transfer Book will remain closed.
  • Equity share capital: Rs 16,59,68,000.
Filed 17:04View Source
Showing 10 of 34 filings